RUMAGREL

This brand name is authorized in Nigeria.

Active ingredients

The drug RUMAGREL contains one active pharmaceutical ingredient (API):

1	Clopidogrel UNII 08I79HTP27 - CLOPIDOGREL BISULFATE
	Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.
	Read more about Clopidogrel

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4688	Tablet	Rumagrel Tablets TAB 75 mg 3 x 10's (in PVC-Alu blisters)	Film Coated Tablet Pink colored, round [diameter 9 mm], biconvex, beveled edge, film-coated tablets debossed with "E" on one side and "34" on the other side 101 RNW-PP-170278 RUMAGREL TABLETS CLOPIDOGREL 75MG OF CLOPIDOGRELEACH FILM COATED TABLETS CONTAINS 2.88MG LACTOSE MONOHYDRATE AND 5.2MG HYDROGENATED CASTOR OIL B4-4688 Drugs Imported Products 3X10'S Prescription Only Medicine (POM) 10/14/2020 Aliyu Mega Pharmaceuticals Nig. Ltd, No. 5 Riyal Quarters, Gombe State, Nigeria 8037033396 aliyumegapharmnigltd@gmail.com M/S. MEDISURE LABORATORIES PAKISTAN (PVT) LTD, A-115 S.I.T.E, SUPER HIGHWAY, KARACHI, PAKISTAN, Pakistan	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AC04	Clopidogrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4688